Company intelligence
FibroBiologics (Nasdaq: FBLG)
FibroBiologics (Nasdaq: FBLG) is a world leader in fibroblast technology to regenerate tissue and cure chronic diseases.
Biotechnology Research
Houston, US
14 employees
1 public signals
About FibroBiologics (Nasdaq: FBLG)
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Verified activity
Signals from FibroBiologics (Nasdaq: FBLG)
1 published signal